Inactive Instrument
Eurofins-Cerep Stock Euronext Paris
Stocks
FR0012413771
Biotechnology & Medical Research
| Market Cap | 77.17M 88.02M 71.14M 66.6M 125M 8.3B 127M 855M 331M 4.1B 331M 323M 14.23B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 56.14M 64.03M 51.75M 48.45M 90.84M 6.04B 92.73M 622M 241M 2.99B 240M 235M 10.35B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.01% |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 11/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodolphe Simonot
BRD | Director/Board Member | - | - |
Paul Ratcliffe
CHM | Chairman | - | 11/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 23/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +4,900.50% | - | - | 88.02M | |
| -0.48% | +7.20% | -5.65% | +3.69% | 46.2B | |
| +2.19% | +11.71% | +393.31% | +609.31% | 38.71B | |
| +2.53% | +13.93% | +21.38% | -10.96% | 31.9B | |
| +1.65% | +3.61% | +16.04% | +55.24% | 31.12B | |
| -4.16% | -2.58% | +8.94% | +26.14% | 23.77B | |
| -0.32% | +12.96% | - | - | 16.2B | |
| +1.37% | +14.53% | +69.64% | +136.34% | 15.05B | |
| +1.00% | +10.30% | +13.31% | +23.36% | 13.74B | |
| +3.63% | +9.53% | +103.97% | +106.25% | 13.42B | |
| Average | +0.74% | +9.14% | +77.62% | +118.67% | 25.57B | |
| Weighted average by Cap. | +0.75% | +8.71% | +88.75% | +138.12% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 46.18M 37.32M 34.94M 65.52M 4.36B 66.88M 449M 174M 2.15B 173M 170M 7.47B | 41.1M 46.87M 37.88M 35.47M 66.51M 4.42B 67.89M 455M 176M 2.19B 176M 172M 7.58B |
| Net income | 7.15M 8.16M 6.59M 6.17M 11.58M 770M 11.82M 79.27M 30.67M 380M 30.64M 29.97M 1.32B | 4.78M 5.45M 4.41M 4.13M 7.74M 515M 7.9M 52.98M 20.5M 254M 20.48M 20.03M 882M |
| Net Debt | -17.25M -19.68M -15.9M -14.89M -27.92M -1.86B -28.5M -191M -73.96M -917M -73.89M -72.27M -3.18B | -21.03M -23.99M -19.39M -18.15M -34.04M -2.26B -34.75M -233M -90.18M -1.12B -90.08M -88.12M -3.88B |
Employees
-
